News release on April 12, 2024

The share issue of Injeq Plc. ended on April 5, 2024, and the investment round did not achieve the goals set for improving the company’s capital structure and increasing working capital. As the target was not reached the Board of Injeq Plc. decided to apply for bankruptcy of its own will on Thursday, April 11, 2024. The bankruptcy application was submitted to the district court of Pirkanmaa by the company on Friday, April 12, 2024.

The district court appoints an administrator for the bankruptcy estate, and the administrator will inform the company’s shareholders and investors after the bankruptcy has started and give instructions, e.g. ownership write-downs, etc. The company has approx. 1,500 shareholders, which is why we ask you to avoid separate contacts with the administrator.

Tiedote osakkeenomistajille / Notice to shareholders

TIEDOTE INJEQ OYJ:N OSAKKEENOMISTAJILLE NOTICE TO SHAREHOLDERS OF INJEQ PLC
Read more »

News release on April 12, 2024

The share issue of Injeq Plc. ended on April 5, 2024, and the investment round did not achieve the goals […]
Read more »

Information to shareholders, March 22nd, 2024

Injeq has started a share issue. The maximum of the financing round is set at €3,000,000. If the €2,000,000 goal […]
Read more »

Injeq webinars by Dr Sauli Palmu and Dr Harri Sievänen

Injeq webinar videos are now available! Welcome to participate in Dr. Sauli Palmu’s lecture “Lumbar punctures in pediatric hemato-oncology” (part […]
Read more »

New distributor agreement with “GENFAX SRL”

We are pleased to announce that GENFAX is appointed as INJEQ’s exclusive distributor in Romania. We are confident that our […]
Read more »

Injeq webinar today, Thursday Feb 22nd, 2024

Welcome to the webinar “Innovation in lumbar punctures” on February 22nd, 2024, at 7:00 pm (Madrid time Zone)   Lecturers […]
Read more »